Norges Bank Takes $66.08 Million Position in Teleflex Incorporated $TFX

Norges Bank acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, Holdings Channel reports. The firm acquired 541,430 shares of the medical technology company’s stock, valued at approximately $66,076,000.

A number of other institutional investors and hedge funds have also bought and sold shares of TFX. Banque Cantonale Vaudoise increased its holdings in Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after purchasing an additional 113 shares during the period. Hantz Financial Services Inc. increased its holdings in Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Teleflex in the third quarter valued at $35,000. V Square Quantitative Management LLC acquired a new stake in Teleflex in the fourth quarter valued at $37,000. Finally, Sound Income Strategies LLC acquired a new stake in Teleflex in the fourth quarter valued at $45,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Performance

Shares of TFX opened at $129.90 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a 50-day moving average of $127.08 and a 200-day moving average of $118.04. The company has a market cap of $5.75 billion, a PE ratio of -5.70, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period last year, the business posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on TFX shares. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Raymond James Financial restated an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Wells Fargo & Company increased their price objective on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $135.00 to $155.00 in a report on Friday, May 8th. Finally, Mizuho set a $140.00 price objective on Teleflex in a report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Teleflex currently has an average rating of “Hold” and an average price target of $144.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.